Old Web
English
Sign In
Acemap
>
authorDetail
>
Robin Harrelson
Robin Harrelson
Wake Forest Baptist Medical Center
Medicine
Immunology
Refractory
Immune system
Cancer
4
Papers
57
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study of the first-in-class mitochondrial metabolism inhibitor CPI-613 in patients with advanced hematologic malignancies.
2017
Journal of Clinical Oncology
Timothy S. Pardee
Denise Levitan
David D. Hurd
Leslie R. Ellis
Scott Isom
Robin Harrelson
Megan Manuel
Sarah Dralle
Susan Lyerly
Bayard L. Powell
Show All
Source
Cite
Save
Citations (0)
A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
2014
Clinical Cancer Research
Timothy S. Pardee
King-Chung Lee
John Luddy
Claudia Maturo
Robert J. Rodriguez
Scott Isom
Lance D. Miller
Kristin M. Stadelman
Denise Levitan
David D. Hurd
Leslie R. Ellis
Robin Harrelson
Megan Manuel
Sarah Dralle
Susan Lyerly
Bayard L. Powell
Show All
Source
Cite
Save
Citations (57)
Impact of Iron Overload On Immune Function for Patients Undergoing Allogeneic Transplants for Hematologic Disorders: Results of Pilot Study
2013
Biology of Blood and Marrow Transplantation
Seema Naik
Ralph B. D'Agostino
Mary Ann Knovich
David D. Grier
Robin Harrelson
Linda C. McPhail
Show All
Source
Cite
Save
Citations (0)
Limited Phase I Trial of Sequential High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia.
2006
Blood
Bayard L. Powell
James Lovato
Claire Kimbrough
Susan Lyerly
Sonya Galloway-Daniels
Cathy Motley
Robin Harrelson
Yi Kong Keung
Mohan C. Thakuri
Istvan Molnar
Denise Levitan
David D. Hurd
Show All
Source
Cite
Save
Citations (0)
1